Welcome to OncologyPRO, the home of Esmo’s educational and scientific resources.

Vertebral fractures in women with invasive breast cancer are frequently related to their malignancy

Receiving 20% or more of immune checkpoint inhibitor infusions for advanced melanoma after 16:30 may be linked to poor survival

Patients with advanced BRAF-mutated melanoma may fare better with first-line nivolumab plus ipilimumab than dabrafenib plus trametinib

Patients with early-stage EGFR-positive non-small-cell lung cancer have a high risk of recurrence within 2 years of resection but individual factors may help predict outcomes

Patients with cancer who survive COVID-19 may develop long-term sequelae that can disrupt oncological treatment and shorten survival

89Zr-pembolizumab imaging may help identify advanced melanoma and lung cancer patients who are likely to respond to the PD-1 inhibitor

Patients aged over 80 years may benefit from immune checkpoint inhibitor therapy but the efficacy in patients with a poor performance status or organ dysfunction is less clear

Head and neck cancer survivors who are current or former smokers are at increased risk of developing lung cancer